Topic

Arrhythmia


Philips upgrades cardiac ultrasound

New Products | Monday, August 30 2010
Royal Philips Electronics has released its upgraded cardiac ultrasound, the iE33 xMATRIX cardiac ultrasound system, which now offers a X5-1 transducer for adult echocardiograms, at the European Society of Cardiology Congress (ESC) this week in Stockholm.
 

St. Jude debuts cardiac mapping system in Japan

New Products | Monday, August 30 2010
The St. Jude Medical EnSite Cardiac Mapping system, a system used to treat cardiac arrhythmias, is now available for use in Japan.
 

AHA statement: CCTA has triage niche in chest pain patients

Top Stories | Thursday, August 26 2010
With the advent of 64-slice CT, coronary CT angiography (CCTA) exams of low-risk patients presenting to the emergency department with chest pain are feasible given the nearly 100 percent negative predictive value of the test, according to a scientific statement from the American Heart Association (AHA) published in the Aug. 17 issue of Circulation.
 

Circ: Integrating 3D CE-CT into ablation mapping improves outcomes

Clinical Studies | Thursday, August 19 2010
Using select data from 3D contrast-enhanced (CE) CT imaging can better locate areas to be ablated in patients with ventricular tachycardia, compared with standard voltage mapping, according to a small study published online July 24 in Circulation: Arrhythmia and Electrophysiology.
 

JACC: New agent IDs heart failure patients likely to have cardiac events

Top Stories | Wednesday, May 19 2010
Researchers prospectively evaluating AdreView, GE Healthcare's iodine-123 meta-iodobenzylguanidine imaging agent, found that the agent identified symptomatic heart failure patients most likely to experience cardiac events, according to the ADMIRE-HF trial published in the May 18 issue of the Journal of the American College of Cardiology.
 

GE invests $5M for cardiovascular genomic diagnostics

Partnerships & Alliances | Sunday, May 16 2010
GE Healthcare and CardioDx, a cardiovascular genomic diagnostics company, have entered into a strategic alliance to co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease.
 

ACC: MRIs can determine when to implant high-risk patients with ICDs

Conference News | Friday, April 02 2010
Written by Kaitlyn Dmyterko
Infarct size measured by MRI can be used as a predictor of ventricular tachycardia and may answer whether or not high-risk patients with an ejection fraction under 35 percent should be implanted with implantable cardioverter-defibrillators (ICDs), said Jeffrey J. Goldberger, MD, from Northwest Memorial Hospital in Chicago, during a presentation at ACC.10 in Atlanta March 15.
 

FDA further approves Stereotaxis' magnetic irrigated catheter

Regulatory News | Thursday, January 14 2010
The FDA has approved Stereotaxis’ Celsius RMT ThermoCool for use with the company’s magnetic navigation system for the treatment of type 1 atrial flutter.
 

AJR: Patient characteristics may serve as image quality predictors of CT scans

Clinical Studies | Tuesday, December 22 2009
Image quality of multi-detector CT scans, when utilized for the noninvasive detection of coronary artery stenosis, can be significantly associated with patient characteristics, including ethnicity, body mass index, heart rate and the presence of breathing artifact, but not with coronary artery calcium (CAC) score at a patient level, based on a study in the January issue of the American Journal of Roentgenology.
 

AHA: New imaging agent may shed light on cardiac sympathetic nerves

Clinical Studies | Tuesday, November 24 2009
Research presented at the 2009 American Heart Association (AHA) scientific sessions in Orlando based on the subanalysis from the ADMIRE-HF phase III clinical trial suggested that imaging of the cardiac sympathetic nerves using the molecular imaging agent 123I-meta-iodobenzylguanidine (123I-MIBG, AdreView; GE Healthcare) may be useful in the assessment of risk for cardiac arrhythmias and cardiac death.
 

FDA clears Biosense Webster’s EP imaging technology

Regulatory News | Thursday, October 15 2009
The FDA has cleared for marketing Biosense Webster’s Carto 3 system, its 3D imaging technology, for use by electrophysiologists (EP) in treating cardiac arrhythmias.
 

CardioComm begins shipping ECG management software

New Products | Wednesday, October 14 2009
CardioComm Solutions has shipped its Global ECG Management System (GEMS) software as part of a multi-year North American licensing agreement with GE Healthcare, and a subsequent OEM agreement.
 

3T 3D delivers fast myocardial viability assessment

Portal Exclusives | Thursday, June 04 2009
The use of a 3D inversion recovery gradient-recalled echo sequence at 3T MRI allows accurate assessment of myocardial infarction without loss of contrast-to-noise ratio compared with a standard 2D technique, according to research published this month in the American Journal of Roentgenology.
 

HRS: Patients with new pacemaker system can safely undergo MRI

Conference News | Friday, May 15 2009
BOSTON--In the MRI environment under specific guidelines, a new pacemaker system facilitates access to this diagnostic imaging technique with no evidence of clinical (bradycardia or tachycardia), subclinical (pacemaker performance) or technical (pacemaker or lead damage) deficits in patients, according to a late-breaking clinical pivotal trial presented May 14 at the 2009 meeting of the Heart Rhythm Society (HRS).
 

CardioNet enters cardiac clinical research services market with Biotel purchase

Wednesday, April 08 2009
CardioNet, a wireless medical technology company for the diagnosis and monitoring of cardiac arrhythmias, has acquired Biotel for approximately $14 million, expanding its portfolio to include cardiac clinical research services.
 

Watson recalls cardiac arrhythmia drug

Industry News | Wednesday, March 25 2009
Watson Pharmaceuticals announced that one lot of 100-count bottles of Propafenone HCL 225 mg tablets, a drug used to treat cardiac arrhythmias, is being voluntarily recalled in the U.S. at the consumer level as a precautionary measure.
 

FDA clears Biosense magnetic, irrigated catheter for radiofrequency ablation

Regulatory News | Sunday, March 01 2009
The FDA has approved Biosense Webster's Navistar RMT ThermoCool catheter for use in operations to eliminate abnormal heart rhythms.


 

Philips, Bard merge image guidance, mapping for cardiac arrhythmias

Partnerships & Alliances | Monday, January 19 2009
Royal Philips Electronics has entered into an agreement with Bard Electrophysiology, a division of C. R. Bard, to co-develop new clinical tools to aid in treating cardiac arrhythmia disorders.
 

Philips, Hansen integrate x-ray, robotic catheter for cardiac arrhythmias

Partnerships & Alliances | Wednesday, January 14 2009
Royal Philips Electronics and Hansen Medical have agreed to co-develop integrated products that may simplify cardiac procedures to diagnose and treat cardiac arrhythmias.
 

Philips, King’s College London to research imaging heart disease

Partnerships & Alliances | Tuesday, October 21 2008
Royal Philips Electronics has signed a new memorandum of understanding for a five-year cardiovascular imaging research collaboration with King’s College London.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics